AVIR

Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc. (AVIR) has 15 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 23, 2026.

  • Industry:Biotechnology
  • CEO:Jean-Pierre Sommadossi
  • Employees:55
  • HQ:Boston, MA, US
  • IPO:2020-10-30

Insider Buying

$51K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$399.3M

latest known value

Source
Purchase$25KMay 21SEC ↗
Murphy Polly A.First filing
Purchase$25KMay 20SEC ↗

Related companies

Atea Pharmaceuticals, Inc. is in the Healthcare sector.